[1]
Diener LC et al. Performance of the integrated management of childhood illness algorithm for diagnosis of HIV-1 infection among African infants. AIDS 26(15):1935-41, 2012.
[2]
Goga A et al. Impact of the national prevention
of mother to child transmission (PMTCT) program on mother-to-child transmission
of HIV (MTCT), South Africa, 2010. 6th International AIDS Society
Conference on HIV Pathogenesis, Treatment and Prevention, abstract MOAC0206,
Rome, 2011.
[3]
Rollins et al. Surveillance of
mother-to-child transmission prevention programmes at immunization clinics: the
case for universal screening. AIDS 21(10): 1341-7, 2012.
[4]
Horwood C et al. Elimination of paediatric HIV in KwaZulu-Natal,
South Africa:
large-scale assessment of interventions for the prevention of mother-to-child
transmission. Bulletin of the World
Health Organization 90:168-175, 2012.
[5]
Hussain A et al. Pregnant women's access to PMTCT and ART services in South Africa
and implications for universal antiretroviral treatment. PLoS ONE 6(12):
e27907, 2011.
[6]
Nwuba
CO et al. A laboratory-based approach to reduce loss to
follow-up of HIV-positive clients. 19th International AIDS Conference, Washington, abstract WEAE0202, 2012.
[7]
GNP+/WAC LTA Report. In
press.
[8]
Dow DE et al. PMTCT
performance among HIV-positive infants in Tanzania. 19th International AIDS Conference, Washington, abstract WEPE198, 2012.
[9]
Dadabhai S et al. Child health outcomes in Blantyre, Malawi:
20-years of data from multiple longitudinal HIV cohorts. 19th International AIDS Conference, Washington, abstract MOPE131, 2012.
[10]
Nyathi M et al. Starting ART early: is there any progress? Experiences and
lessons from Zimbabwe’s
largest child cohort. 19th International AIDS Conference, Washington, abstract MOPE195, 2012.
[11]
Atukunda R et al. Factors associated with mortality among paediatric patients
on antiretroviral therapy in 18 AIDSRelief sites in Uganda: a cause for concern? 19th International AIDS Conference, Washington, abstract MOPE039, 2012.
[12]
Zanoni BC et al. Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa. PLoS ONE 6(7): e22706, 2011.
[13] Rahma NE et al. Mortality
among HIV-positive children after receiving highly active antiretroviral
therapy at OMACU Center,
Khartoum, Sudan. 19th International AIDS Conference, Washington, abstract TUPE038, 2012.
[14]
Vermund SH et al. Poor clinical outcomes for HIV infected
children on antiretroviral therapy in rural Mozambique: need for quality improvement and continuing program/community development in PEPFAR. 19th International AIDS Conference, Washington, abstract MOPE068, 2012.
[15] Violari A et al. Early antiretroviral therapy and
mortality among HIV-infected infants. N Engl J Med.359(21):2233-2244,
2008.
[16]
Ibid.
[17] Nyathi M et al. Starting ART early: is there any progress? Experiences and
lessons from Zimbabwe’s
largest child cohort. 19th International AIDS Conference, Washington, abstract MOPE195, 2012.
[18]
Mushavi A et al. Retention of children in HIV treatment and care programmes. 19th International AIDS Conference, Washington, 2012.
[19] Abubakar
A et al. Towards an HIV-free generation: prospects and challenges
of determining the outcomes of prevention of mother-to-child transmission of
HIV program in hospitals in Kwara State, north central Nigeria. 19th International AIDS Conference, Washington, abstract WEPE188, 2012.
[20]
Dube Q et al. Implementing early infant diagnosis of HIV
infection at the primary care level: experiences and challenges in Malawi. Bulletin of the World
Health Organization 90:699-704, 2012.
[21]
Schouten EJ et al. More HIV-positive infants and mothers identified through
HIV testing in immunization clinics. 19th International AIDS
Conference, Washington, abstract THAC0102, 2012.
[22]
Landes M et al. Mortality and
health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in
Malawi. 19th International AIDS Conference, Washington,
abstract WEPE161, 2012.
[23]
van Lettow M et al. Uptake and
outcomes of a prevention-of mother-to-child transmission (PMTCT) program in
Zomba district, Malawi.
BMC Public Health 11:426, 2011.
[24]
McCollum ED et al. Clinical diagnosis versus expedited virologic testing for HIV infection in hospitalized Malawian infants: a randomized controlled proof-of-concept trial of point-of-care infant testing. 19th
International AIDS Conference, Washington, abstract LBPE13, 2012.
[25]
Sherman G Recognizing risk in HIV-exposed and -infected infants and
children. Diagnosing HIV infection in infants: are we there yet? 19th
Conference on Retroviruses and Opportunistic Infections, Seattle, 2012.
[26]
Chamie G et al. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural
Uganda. PLoS One 7(8): e43400, 2012.
[27]
Jani IV et al. Effect of point-of-care CD4 cell count tests on retention of
patients and rates of antiretroviral therapy initiation in primary health
clinics: an observational cohort study. The Lancet 378 (9802): 1572-9, 2011.
[28]
Bergeron M et al. Performance of the PointCare NOW system for CD4 counting in
HIV patients based on five independent evaluations. PLoS One 7(8): e41166,
2012.
[29] Mahomva AI et al. An innovative, rapid national scale-up
of effective PMTCT services in a resource-limited setting to facilitate virtual
elimination of new pediatric HIV infections by 2015: A Zimbabwe experience.
19th
International AIDS Conference, Washington, abstract WEPE737, 2012.
[30]
Muchedzi
et al. Evaluating the effect of the use of point-of-care CD4 machines on access to
eligibility screening and ART initiation for HIV-positive pregnant women in Zimbabwe: towards elimination of new paediatric HIV infection by 2015. 19th
International AIDS Conference, Washington, abstract TUPDE0204, 2012.